• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

MundiPharma International Corporation Limited - Articles and news items


Verastem licenses Duvelisib from Infinity Pharmaceuticals for $28 million

Industry news / 3 November 2016 / Niamh Louise Marriott, Digital Content Producer

Verastem licensed exclusive worldwide rights to develop and commercialise Infinity’s oncology product candidate duvelisib…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +